T1D is a complex autoimmune condition characterized by the destruction of insulin-producing cells in the pancreas, leading to chronic high blood sugar and the need for lifelong insulin treatment. Its acute and long-term complications significantly impact the quality and expectancy of life.
Therefore, research in this field is essential to broaden our understanding of this condition, generate evidence to guide decision-making, and help improve the care, well-being, and health outcomes for people living with T1D, their caregivers, and health systems.
